School of Pharmacy and Medical Sciences, University of South Australia, Adelaide, SA, AUS.
School of Pharmacy and Medical Sciences, University of South Australia, Adelaide, SA, AUS.
Accid Anal Prev. 2019 May;126:160-172. doi: 10.1016/j.aap.2018.01.026. Epub 2018 May 7.
Self-assessment is the most common method for monitoring performance and safety in the workplace. However, discrepancies between subjective and objective measures have increased interest in physiological assessment of performance. In a double-blind placebo-controlled study, 23 healthy adults were randomly assigned to either a placebo (n = 11; 5 F, 6 M) or caffeine condition (n = 12; 4 F, 8 M) while undergoing 50 h (i.e. two days) of total sleep deprivation. In previous work, higher salivary alpha-amylase (sAA) levels were associated with improved psychomotor vigilance and simulated driving performance in the placebo condition. In this follow-up article, the effects of strategic caffeine administration on the previously reported diurnal profiles of sAA and performance, and the association between sAA and neurobehavioural performance were investigated. Participants were given a 10 h baseline sleep opportunity (monitored via standard polysomnography techniques) prior to undergoing sleep deprivation (total sleep time: placebo = 8.83 ± 0.48 h; caffeine = 9.01 ± 0.48 h). During sleep deprivation, caffeine gum (200 mg) was administered at 01:00 h, 03:00 h, 05:00 h, and 07:00 h to participants in the caffeine condition (n = 12). This strategic administration of caffeine gum (200 mg) has been shown to be effective at maintaining cognitive performance during extended wakefulness. Saliva samples were collected, and psychomotor vigilance and simulated driving performance assessed at three-hour intervals throughout wakefulness. Caffeine effects on diurnal variability were compared with previously reported findings in the placebo condition (n = 11). The impact of caffeine on the circadian profile of sAA coincided with changes in neurobehavioural performance. Higher sAA levels were associated with improved performance on the psychomotor vigilance test during the first 24 h of wakefulness in the caffeine condition. However, only the association between sAA and response speed (i.e. reciprocal-transform of mean reaction time) was consistent across both days of sleep deprivation. The association between sAA and driving performance was not consistent across both days of sleep deprivation. Results show that the relationship between sAA and reciprocal-transform of mean reaction time on the psychomotor vigilance test persisted in the presence of caffeine, however the association was relatively weaker as compared with the placebo condition.
自我评估是监测工作场所绩效和安全的最常用方法。然而,主观和客观测量之间的差异增加了对生理绩效评估的兴趣。在一项双盲安慰剂对照研究中,23 名健康成年人被随机分配到安慰剂组(n=11;5 名女性,6 名男性)或咖啡因组(n=12;4 名女性,8 名男性),同时接受 50 小时(即两天)的完全睡眠剥夺。在之前的工作中,较高的唾液 α-淀粉酶(sAA)水平与安慰剂条件下的警觉性和模拟驾驶性能的提高有关。在这篇后续文章中,研究了策略性咖啡因给药对之前报道的 sAA 和性能的昼夜节律模式的影响,以及 sAA 与神经行为表现之间的关系。参与者在进行睡眠剥夺前有 10 小时的基线睡眠机会(通过标准多导睡眠图技术监测)(总睡眠时间:安慰剂组=8.83±0.48 小时;咖啡因组=9.01±0.48 小时)。在睡眠剥夺期间,咖啡因口香糖(200mg)在 01:00 时、03:00 时、05:00 时和 07:00 时给予咖啡因组(n=12)的参与者。这种策略性的咖啡因口香糖(200mg)给药已被证明在延长清醒时间内维持认知表现有效。在整个清醒期间,每隔 3 小时收集唾液样本,并评估警觉性和模拟驾驶性能。将咖啡因对昼夜变化的影响与之前在安慰剂条件下(n=11)的发现进行了比较。咖啡因对 sAA 昼夜节律的影响与神经行为表现的变化一致。在咖啡因组的前 24 小时清醒期间,较高的 sAA 水平与警觉性测试的表现提高有关。然而,只有 sAA 与反应速度(即平均反应时间的倒数变换)之间的关联在睡眠剥夺的两天内是一致的。sAA 与驾驶性能之间的关联在睡眠剥夺的两天内并不一致。结果表明,在咖啡因存在的情况下,sAA 与警觉性测试中平均反应时间倒数变换之间的关系仍然存在,但与安慰剂条件相比,这种关联相对较弱。